comparemela.com

Page 12 - Benzinga All Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cingulate and ADHD Expert Dr Ann Childress, MD to Participate in Benzinga All Live Access Event

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesKansas cityMatt krepsThomas daltonLas vegasMelyssa weibleShanej schafferBenzinga youtubeAnn childressAnnc childressAmerican psychiatric associationAmerican academy of childDarrow associatesCingulate incClinical research of southern nevadaNevada psychiatric association

Mullen Automotive CEO to Be Featured on Benzinga s All

David Michery, CEO and chairman of Mullen Automotive, to be interviewed Friday, June 3, 2022, at 11 a.m. ET.

United statesLos angelesDavid micheryExchange commissionWire service contactMullen automotive incSecurities exchangeMullen automotiveAll access seriesAll accessSpencer israelAll access series event detailsBenzinga all access seriesDrive tourSouthern californiaSouthern california based

Cingulate and ADHD Expert Dr Ann Childress, MD to Participate in Benzinga All Live Access Event

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesKansas cityMatt krepsThomas daltonLas vegasMelyssa weibleShanej schafferBenzinga youtubeAnn childressAnnc childressAmerican psychiatric associationAmerican academy of childDarrow associatesCingulate incClinical research of southern nevadaNevada psychiatric association

Cingulate and ADHD Expert Dr Ann Childress, MD to

KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary.

United statesKansas cityMatt krepsThomas daltonLas vegasMelyssa weibleShanej schafferBenzinga youtubeAnn childressAnnc childressAmerican psychiatric associationAmerican academy of childDarrow associatesCingulate incClinical research of southern nevadaNevada psychiatric association

Cingulate and ADHD Expert Dr Ann Childress, MD to Participate in Benzinga All Live Access Event

02.06.2022 - KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a pipeline .

United statesMatt krepsThomas daltonBenzinga youtubeAnn childressLas vegasMelyssa weibleAnnc childressAmerican psychiatric associationAmerican academy of childDarrow associatesCingulate incClinical research of southern nevadaNevada psychiatric associationElixir health public relationsAmerican professional society

vimarsana © 2020. All Rights Reserved.